Approved Study Database
Ref. No. | Scientific Title | Principal investigator |
---|---|---|
2016.547 | A prospective study of pregnant women with and without IBD in order to better understand the patterns of bacterial transmission from the mother to the baby. |
Prof. NG Siew Chien 黃秀娟教授 |
2015.601 | Knowledge and Attitudes towards pregnancy in women with Inflammatory Bowel Disease |
Prof. NG Siew Chien 黃秀娟 |
2017.495 | The ENIGMA II Study: Eastern Inflammatory Bowel Disease Gut Microbiota |
Prof. NG Siew Chien 黃秀娟教授 |
2014.183 | Fecal Microbiota Transplantation (FMT) for Moderate to Severe Clostridium Difficile Infection (CDI): A Randomised Study with Concurrent Stool Microbiota Assessment | Prof. NG Siew Chien |
2015.528 | A Combined Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluating the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis |
Prof. NG Siew Chien 黃秀娟教授 |
2016.033 | Development of donor screening and systematic stool bank for Fecal Microbiota Transplantation (Stool bank study) | Prof. NG Siew Chien |
2016.407 | Gut Microbiota of Patients with IBD Living In Rural and Urban Area |
Prof. NG Siew Chien 黃秀娟 |
2017.260 | The Fecal Microbiota Transplantation Registry (FMTR) |
Prof. NG Siew Chien 黃秀娟教授 |
2015.471 | A Randomized, Double-Blind, Double-Dummy, Multicenter, Active-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab IV Compared to Adalimumab SC in Subjects With Ulcerative Colitis |
Prof. NG Siew Chien 黃秀娟 |
2018.070 | When should low-dose aspirin be resumed after peptic ulcer bleeding? A randomized controlled trial |
Prof. NG Siew Chien 黃秀娟教授 |
2018.337 | A Survey about patient's medication adherence and disease-related knowledge on Inflammatory Bowel Disease in Hong Kong |
Dr. NG Siew Chien 黃秀娟 |
2020.575 | ICARUS-IBD: International study of COVID-19 Antibody Response Under Sustained immune suppression in IBD | Prof. NG Siew Chien |
2018.443 | Safety and Efficacy of Fecal Microbiota Transplantation: A Pilot Study |
Prof. NG Siew Chien 黃秀娟教授 |
2018.444 | An open-label pilot study of fecal microbiota transplant (FMT) to induce weight loss in obese subjects |
Prof. NG Siew Chien 黃秀娟教授 |
2020.407 | An evaluation of a synbiotic formula for symptom improvement in hospitalised patients with COVID-19 infection | Prof. NG Siew Chien |
2020.400 | Evaluation of a synbiotic formula in patient with COVID-19 |
Prof. NG Siew Chien 黃秀娟 |
2020.399 | Evaluation of a synbiotic formula in hospitalised patients with COVID-19 infection | Prof. NG Siew Chien |
2018.219 | A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Response to Biological Therapy in Patients with Crohn’s Disease |
Prof. NG Siew Chien 黃秀娟教授 |
2020.574 | Global IBD Visualization of Epidemiology Studies (GIVES) in the 21st Century (GIVES-21) | Prof. NG Siew Chien |
2018.207 | Access to Health Care, Work, and Quality of Life In Persons With Inflammatory Bowel Disease |
Prof. NG Siew Chien 黃秀娟教授 |
2018.218 | A prospective longitudinal study of fecal microbiome and calprotectin to predict relapse in patients with inflammatory bowel disease | Prof. NG Siew Chien |
2020.613 | Evaluation of a synbiotic immunity formula in patients at risk of infections |
Prof. NG Siew Chien 黃秀娟 |
2019.576 | Mother-to-Infant Transfer of Bacteriome, Fungome, Virome, and Metabolome in Health and Crohn's disease (MoMmy-CD) |
Prof. NG Siew Chien 黃秀娟 |
2011.598 | A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission with GSK1605786A in Subjects with Moderately-to-Severely Active Crohn | Dr Ng Siew Chien |
2013.362 | Curcumin Add-on Therapy for Induction of Remission in Mild-to-Moderate Ulcerative Colitis: A Prospective, Randomized, Placebo-Controlled, Double-Blind Study | Prof Ng Siew Chien |
2011.599 | An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects with Crohn | Dr Ng Siew Chien |
2011.597 | A 52 week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn's Disease | Dr Ng Siew Chien |
2014.053 | Oral 5-aminosalicyclic Acid Withdrawal in Long Standing Inactive Ulcerative Colitis: A Double-blind, Randomized, Placebo-controlled Trial | Prof. NG Siew Chien |
2011.528 | Chief Project Title: The Role of Interferon Gamma Releasing Assays (IGRA) in Screening and Monitoring for Tuberculosis during Anti-TNF therapy in Patients with Immune-mediated Inflammatory Disease (IMID) Sub-study 1: To evaluate the IGRA status of IBD patients receiving anti-TNF therapy or other immunosuppressive drugs Sub-Study 2: A prospective study of serial interferon-gamma release assays (IGRA) for the diagnosis of tuberculosis (TB) infection in patients with immune-mediated inflammatory diseases (IMID) treated with biologics Sub-Study 3: A retrospective study on the rate of tuberculosis infection in patients treated with biologics | Prof. NG Siew Chien |
2014.113 | Identification and Characterization of the Gut Microbiota in Incident Inflammatory Bowel Disease Individuals from a Population-based Cohort | Prof NG Siew Chien |
2010.190 | Manipulation of Visceral Hypersensitivity with Probiotic Bacteria in Irritable Bowel Syndrome (IBS Probiotic Study) | Dr Ng Siew Chien |
2010.259 | A Retrospective Review of Colonoscopy Performance, Quality and Outcome | Dr. NG Siew Chien |
2024.158 | Faecal microbiota transplantation for insomnia disorder: a randomized, double-blind, placebo-controlled trial |
Prof. NG Siew Chien 黃秀娟 |
2010.028 | A study of the gut microbiota in the healthy population, patients with inflammatory bowel disease and their relatives (IBD Microbe Study) | Dr. NG Siew Chien |
2012.494 | A cross-sectional survey on the quality of life and psychological outcome of Chinese Crohn's disease patients in Hong Kong | Prof Ng Siew Chien |
2014.026 | Biobank - Investigating the Gut Microbiota, Genetics, Epigenetics and Metabolites | Prof. NG Siew Chien |
2011.290 | Clinical Outcomes and Mortality in Patients Presenting with Upper Gastrointestinal Bleeding on Anti-thrombotic agents and Non-steroidal Anti-inflammatory Drugs | Dr. Ng Siew Chien |
2013.093 | The Nixon-TAM Hong Kong IBD Registry | Prof. NG Siew Chien |
2010.141 | Genome Wide Association (GWA) Study in Chinese Patients with Inflammatory Bowel Disease (IBD GWA Study) | Dr. NG Siew Chien |
2014.027 | The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative Colitis | Prof. NG Siew Chien |
2012.493 | Prevalence and clinical course of chronic hepatitis B infection in patients with inflammatory bowel disease and rheumatologic diseases | Prof Ng Siew Chien |
2010.508 | Investigating the Epidemiology of Inflammatory Bowel Disease in Hong Kong: An Inception Cohort and Follow up Study (IBD EPI Study) | Dr. NG Siew Chien |
2010.198 | A Prospective Study into the Risk of Colorectal Neoplasms in individuals With a Family History of Advanced Adenomas | Dr. NG Siew Chien |
2023.297 | The Effectiveness of a Psycho-education Program in improving Stoma Care Self-efficacy and Health-related Quality of Life for Patient after Colorectal Cancer Surgery: A Randomized Controlled Trial | Ms. NG Shuk Ching |
2020.616 | Effect of Substitution Rate on Solute Clearances for Patients Receiving Pre-dilution On-line Hemodiafiltration |
Dr. NG Sheung Wah 吳尚華 |
2017.092 | Symptom Clusters and Their Impact on Quality of Life, Functional Status, Health Care Utilisation and Mortality in End-stage Renal Disease Undergoing Dialysis Therapy: A Longitudinal Mixed Methods Study |
Mr. NG Shek Nam 吳碩南 |
2017.572 | The Validation of the Specific Activity Scale Chinese Version for Day Patients with Coronary Artery Disease in Chinese Population |
Miss NG Po Chu 吳寶珠 |
2011.046 | Reliability and Validity of the Self-Administered Shortness of Breath Questionnaire | Ms NG PO CHU |
2023.156 | Clinical effectiveness of self-management program by Occupational Therapy with tailor-made oral splintage on improving trismus in head and neck cancer survivors after cancer therapy | Miss NG Po Chu |
2010.045 | The regulatory role of has-miR-1290 in response to Gram-positive bacterial peptidoglycan (PGN) challenge in human cord blood neutrophils | Prof Ng Pak-cheung |
Page 83 of 262.